"Polydipsia" means "excessive thirst." It can be a symptom of medical conditions such as diabetes, a psychological symptom, ...

(via Reactions) When seawater and freshwater mix, a surprising amount of energy is released. Norway tried to capture this energy using an osmotic power plant, but the plant mysteriously and abruptly ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

Can People With Diabetes Have Artificial Sweeteners? Yes, they can. Artificial sweeteners are just as sweet — and sometimes, up to 700 times sweeter — than regular sugar, but they have no ...

There's little research on how these additives impact health, but one new study has indicated consuming certain clusters is linked to an increase in type 2 diabetes. The research, published Tuesday in ...

The government plans to install reverse osmosis packaged units to treat toxic acid mine drainage (AMD) to optimise the use of water and to help alleviate water stress in Gauteng. The department of ...

Diabetes is known to cause many medical issues, from heart disease to vision problems — and now a new study suggests it could also impact memory and other cognitive functions. After observing ...

Of these, 110 studies looked at gestational diabetes – which develops during pregnancy and usually goes away after birth – and 80 looked at pre-gestational diabetes, when a woman has a type 1 ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA ...

FAT jabs may lower the risk of the UK's biggest killer, according to a study of almost 400,000 adults with type 2 diabetes. The research, published in JAMA Neurology, examined two types of drugs ...

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration. By Gina Kolata Robert F. Kennedy Jr ...